Janney Montgomery Scott LLC Sells 344 Shares of Invesco Biotechnology & Genome ETF $PBE

Janney Montgomery Scott LLC reduced its holdings in shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) by 6.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,080 shares of the company’s stock after selling 344 shares during the period. Janney Montgomery Scott LLC owned 0.15% of Invesco Biotechnology & Genome ETF worth $326,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the business. Gerber Kawasaki Wealth & Investment Management grew its holdings in Invesco Biotechnology & Genome ETF by 9.1% during the 1st quarter. Gerber Kawasaki Wealth & Investment Management now owns 243,959 shares of the company’s stock worth $15,477,000 after acquiring an additional 20,391 shares during the period. Royal Bank of Canada grew its holdings in Invesco Biotechnology & Genome ETF by 22.3% during the 1st quarter. Royal Bank of Canada now owns 75,402 shares of the company’s stock worth $4,783,000 after acquiring an additional 13,767 shares during the period. Goldman Sachs Group Inc. grew its holdings in Invesco Biotechnology & Genome ETF by 5.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 37,657 shares of the company’s stock worth $2,389,000 after acquiring an additional 2,103 shares during the period. Wealth Enhancement Advisory Services LLC grew its holdings in Invesco Biotechnology & Genome ETF by 78.1% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 7,242 shares of the company’s stock worth $459,000 after acquiring an additional 3,176 shares during the period. Finally, Signet Financial Management LLC grew its holdings in Invesco Biotechnology & Genome ETF by 3.9% during the 2nd quarter. Signet Financial Management LLC now owns 4,351 shares of the company’s stock worth $279,000 after acquiring an additional 164 shares during the period.

Invesco Biotechnology & Genome ETF Trading Up 0.7%

Shares of Invesco Biotechnology & Genome ETF stock opened at $72.23 on Monday. The business has a 50-day moving average price of $69.72 and a two-hundred day moving average price of $65.35. Invesco Biotechnology & Genome ETF has a 1-year low of $54.52 and a 1-year high of $73.03. The company has a market cap of $226.80 million, a P/E ratio of 20.44 and a beta of 0.87.

Invesco Biotechnology & Genome ETF Profile

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies.